SMDPY.US Sumitomo Pharma Co. Ltd

Healthcare Pharmaceuticals USA Stocks
12.08 USD
Close of Nov 17, 2026
7.84 24.48
Market cap
USD 5.42B
P/E
18.0x
P/B
2.12x
ROE
17.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is SMDPY.US undervalued?

Graham number
Price12.08
Graham value9.27
Premium30.3%

SMDPY.US trades 30.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sumitomo Pharma Co. Ltd fundamental analysis

No fundamental analysis for Sumitomo Pharma Co. Ltd yet.

Sumitomo Pharma Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sumitomo Pharma Co. Ltd

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicine…

Full company profile